No black box warning on record for Darzalex Faspro
As of the latest FDA labeling reviewed, Darzalex Faspro (DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT)) does not carry a black box warning. Standard warnings and precautions still apply — see the full Darzalex Faspro medicine page for the complete safety profile.